Screening depression among institutionalized older Chinese men by minimum data set: we need a new instrument

TitleScreening depression among institutionalized older Chinese men by minimum data set: we need a new instrument
Publication TypeJournal Article
Year of Publication2011
AuthorsLiang C-K, Chen L-K, Tsai C-F, Su T-P, Lo Y-K, Lan C-F, Hwang S-J
JournalJournal of geriatric psychiatry and neurology
Volume24
Issue4
Pagination179-183
Date PublishedDec
ISBN Number0891-9887
Accession Number19487581
Keywords*Homes for the Aged/statistics & numerical data/trends, *Nursing Homes/statistics & numerical data/trends, Aged, Aged, 80 and over, Anxiety Disorders/diagnosis/epidemiology, Depression/*diagnosis/epidemiology, Geriatric Assessment/*methods/statistics & numerical data, Humans, Male, Mass Screening/*methods/statistics & numerical data/trends, Mood Disorders/diagnosis/epidemiology, Psychiatric Status Rating Scales/*standards/statistics & numerical data, Psychometrics/*instrumentation/statistics & numerical data, Taiwan/epidemiology
Abstract

Objective: To compare the effectiveness of the Minimum Data Set-based Depression Rating Scale (MDS-DRS) and Geriatric Depression Scale (GDS) in screening depression among older institutionalized Chinese men living in Taiwan.Method: MDS Nursing Home 2.1 Chinese version, Mini-Mental State Examination (MMSE), and short form Geriatric Depression Scale (GDS-15) were used among elderly residents in Banciao Veterans Home. Screening results of MDS-DRS and GDS-15, and relationship between 16 MDS Mood and Anxiety symptoms and depression were evaluated.Results: The prevalence of depression defined by MDS-DRS and GDS were 0.2% and 8.7%, respectively. Multiple logistic regression disclosed that E1a (OR: 12.9, 95% CI: 2.8-58.8, p = 0.001), E1k (OR: 15.6, 95% CI: 5.6-43.5, p < 0.001), and E1l (OR: 22.2, 95% CI: 6.1-83.3, p < 0.001) were all independent associative factors for GDS-defined depression but only explained 51.9% of all depressive subjects.Conclusions: The effectiveness of MDS-DRS is limited, and a new MDS-based depression screening instrument is needed.
DOI10.1177/0891988709335795